ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 672210 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 672210; 2) Community: the network communities that were significantly associated with the response to NSC 672210; 3) Molecule: the relationships between components within communities and NSC 672210; 4) MDR: the compounds that were significantly associated with the NSC 672210.

NSC Compound Enrichment Correlation
NSC 151982 Null 0.00338965595190746 0.44458425
NSC 305802 2,4-Quinazolinediamine, 5,6,7,8-tetrahydro-6-(2-naphthalenylsulfonyl)- 0.00338965595190746 0.32296883
NSC 377852 Null 0.00338965595190746 0.51252978
NSC 679516 Null 0.00338965595190746 0.28981475
NSC 718781 Erlotinib hydrochloride 0.00338965595190746 -0.27474525
NSC 688235 Null 0.00349006332443474 0.14865479
NSC 753139 benzimidazol -thiosemicarbazone derivative 0.00349006332443474 0.16870743
NSC 750493 2-(2-hydroxyphenyl)-3-[5-(1H-imidazol-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-one 0.00361053534040666 0.44886114
NSC 102225 Null 0.00485717408280859 0.51807927
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.00485717408280859 0.16415951
Total:110  Current:12    [First] [Prev] [Next] [Last]